 |
 |
 |
The ‘terahertz gap’ – where until recently bright sources of light and sensitive means of detection did not exist – encompasses frequencies invisible to the naked eye in the electromagnetic spectrum, lying between microwave and infrared. TeraView’s TPI™ core technology harnesses terahertz (THz), which is intrinsically safe, non-invasive and non-destructive, to create a powerful spectroscopic imaging technique for characterizing molecular structures. TPI™ enables 3D imaging of structures and materials, and the measurement of the unique spectral fingerprints of different chemical and physical forms.
TeraView is the first company to develop technologies which commercially exploit terahertz, the last unexplored region of the electromagnetic spectrum. Our patented terahertz technology creates spectroscopic information and 3D image maps with unique spectroscopic signatures not found at other wavelengths. It resolves many of the questions left unanswered by complementary techniques, such as optical imaging, raman and infrared. Terahertz technology also produces faster results than X-ray and in the pharma industry enables non-destructive, internal, chemical analysis of tablets, capsules and other dosage forms.
Terahertz light has remarkable properties. Many common materials and living tissues are semi-transparent and have ‘Terahertz fingerprints’, permitting them to be imaged, identified, and analyzed. Moreover, the non-ionizing properties of terahertz radiation and the relatively low power levels used indicate that it is safe. These unique properties, combined with TeraView's extensive experience and patent portfolio offer new opportunities to the pharma industry for research, development and manufacture. |
 |
|
|
|
|